Drug Combo Offers Long-Term Benefits in SLE MedPage Today WASHINGTON -- An 18-month treatment with the combination of rituximab and cyclophosphamide (Cytoxan) stopped progression of systemic lupus erythematosus (SLE) for at least 3 years, researchers here. The mean SLE Disease Activity Index (SLEDAI) ... |
